{"count": 3, "results": [{"_id": "37173821", "pmid": 37173821, "title": "Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.", "journal": "J Clin Pharmacol", "authors": ["Krysiak R", "Kowalcze K", "Okopień B"], "date": "2023-05-12T00:00:00Z", "doi": "10.1002/jcph.2268", "meta_date_publication": "2023 May 12", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50276.016, "text_hl": "Impact of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ on Cardiometabolic Risk Factors in Sisters of @SPECIES_9606 @@@Women@@@ With @<m>DISEASE_Polycystic_Ovary_Syndrome</m> @DISEASE_MESH:D011085 @@@Polycystic Ovary Syndrome@@@.", "citations": {"NLM": "Krysiak R, Kowalcze K, Okopień B. Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome. J Clin Pharmacol. 2023 May 12;():. PMID: 37173821", "BibTeX": "@article{37173821, title={Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.}, author={Krysiak R and Kowalcze K and Okopień B}, journal={J Clin Pharmacol}}"}}, {"_id": "34756399", "pmid": 34756399, "title": "Effects of lisinopril treatment on the pathophysiology of PCOS and plasminogen activator inhibitor-1 concentrations in rats.", "journal": "Reprod Biomed Online", "authors": ["Coskun B", "Ercan CM", "Togrul C", "Ozhamam EU", "Coskun B", "Eren M", "Vaughan DE"], "date": "2020-09-14T00:00:00Z", "doi": "10.1016/j.rbmo.2020.09.011", "meta_date_publication": "2020 Sep 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50270.418, "text_hl": "Effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ treatment on the pathophysiology of @<m>DISEASE_Polycystic_Ovary_Syndrome</m> @DISEASE_MESH:D011085 @@@PCOS@@@ and @GENE_SERPINE1 @GENE_24617 @@@plasminogen activator inhibitor-1@@@ concentrations in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Coskun B, Ercan CM, Togrul C, Ozhamam EU, Coskun B, Eren M, Vaughan DE. Effects of lisinopril treatment on the pathophysiology of PCOS and plasminogen activator inhibitor-1 concentrations in rats. Reprod Biomed Online. 2020 Sep 14;():. PMID: 34756399", "BibTeX": "@article{34756399, title={Effects of lisinopril treatment on the pathophysiology of PCOS and plasminogen activator inhibitor-1 concentrations in rats.}, author={Coskun B and Ercan CM and Togrul C and Ozhamam EU and Coskun B and Eren M and Vaughan DE}, journal={Reprod Biomed Online}}"}}, {"_id": "11872207", "pmid": 11872207, "title": "Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome.", "journal": "Fertil Steril", "authors": ["Hacihanefioglu B", "Somunkiran A", "Mahmutoglu I", "Sercelik A", "Toptani S", "Kervancioglu E"], "date": "2002-03-01T00:00:00Z", "doi": "10.1016/s0015-0282(01)03210-1", "meta_date_publication": "2002 Mar", "meta_volume": "77", "meta_issue": "3", "meta_pages": "526-8", "score": 50063.254, "text_hl": "@SPECIES_9606 @@@PATIENT@@@(S): Ten @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Polycystic_Ovary_Syndrome</m> @DISEASE_MESH:D011085 @@@PCOS@@@. INTERVENTION(S): @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@, 10 mg/day, for 4 weeks. ", "citations": {"NLM": "Hacihanefioglu B, Somunkiran A, Mahmutoglu I, Sercelik A, Toptani S, Kervancioglu E. Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome. Fertil Steril. 2002 Mar;77(3):526-8. PMID: 11872207", "BibTeX": "@article{11872207, title={Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome.}, author={Hacihanefioglu B and Somunkiran A and Mahmutoglu I and Sercelik A and Toptani S and Kervancioglu E}, journal={Fertil Steril}, volume={77}, number={3}, pages={526-8}}"}}]}